Encarnacion G. F.
- Country
- Spain
- Department
- Oncology
Research Overview
- Phase III Randomized Trial of Trastuzumab, Alpelisib, and Fulvestrant Versus Trastuzumab and Chemotherapy in PIK3CA-Mutated HER2+ Advanced Breast Cancer
- Evaluation of Allogenic Adipose-Derived Mesenchymal Stem Cells on Fibrin-Hyaluronic Matrix for Venous Ulcer Treatment in Lower Limbs
- Phase 1b/2 Study of Nadunolimab with Gemcitabine and Carboplatin in Advanced Triple Negative Breast Cancer Patients
Data & Insights
Has run more than one trial at 38 of 152 partner sites.
Specializations
Regenerative Medicine
Specialized in exploring adipose tissue stem cell applications for wound healing and tissue regeneration, with particular emphasis on treating chronic vascular conditions.
- Stem Cell Therapy
- Tissue Engineering
- Biological Matrix Integration
Active investigation of innovative cellular-based treatments for chronic wounds.
Vascular Medicine
Focused on the treatment of venous ulcers of the lower limbs, investigating advanced therapeutic approaches for chronic venous insufficiency complications.
- Chronic Wound Management
- Venous Disease Treatment
- Lower Limb Pathologies
Developing novel strategies for complex wound healing in vascular conditions.
Clinical Safety Studies
Conducts research on the feasibility and safety of advanced therapeutic applications, particularly in regenerative medicine treatments.
- Treatment Safety Assessment
- Clinical Outcome Evaluation
- Therapeutic Protocol Development
Expertise in evaluating innovative treatments for chronic wound conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.